About Exponent, Inc
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 different technical disciplines to solve complicated issues facing industry and government. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California. Address: 149 Commonwealth Drive, Menlo Park, CA, United States, 94025
Exponent, Inc News and around…
Latest news about Exponent, Inc (EXPO) common stock and company :
MENLO PARK, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today announced that Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will present to the investment community at the following investor conferences: Berenberg Conference USA 2022Date: Wednesday, May 25, 2022Time: 10:15am – 11:00am ET Stifel Cross Sector Insight Conference 2022Date: Wednesday, June 8, 2022Time: 1:15pm – 1:45p
The heavy selling pressure might have exhausted for Exponent (EXPO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Exponent (EXPO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Exponent (EXPO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Exponent (NASDAQ:EXPO) has had a rough month with its share price down 16%. However, a closer look at its sound...
Exponent (EXPO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Exponent (EXPO) delivered earnings and revenue surprises of 7.69% and 2.05%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
MENLO PARK, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.24 per share of common stock to be paid on June 24, 2022 to all common stockholders of record as of June 10, 2022. Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September and December. Future declarations of quarterly dividends and the establishment of future record and payme
MENLO PARK, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2022 ended April 1, 2022. “We are pleased to report year-over-year growth in revenue and EBITDA1, once again demonstrating the strength of our business model and our ability to execute on our long-term strategy. We saw strong demand across the business for our multidisciplinary expertise, tailored solutions, and speed, which provide stability
Symbols mentioned in this story: IJR, SWN, IRT, EXPO Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can be traded back and forth just like stocks, but can also be created or destroyed to accommodate investor demand..
In trading on Friday, shares of Exponent Inc. (EXPO) crossed below their 200 day moving average of $107.76, changing hands as low as $106.81 per share..
To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...
Exponent Inc's(NASDAQ: EXPO)price target has been raised to $120(an upside of 12%) from $115 ...
MENLO PARK, Calif., April 04, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO), today announced that it will report first quarter of fiscal year 2022 financial results for the period ended April 1, 2022 following the close of the market on Thursday, April 28, 2022. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to di
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the WisdomTree US.
AMED, CACC, and EXPO have been added to the Zacks Rank #5 (Strong Sell) List on March 4, 2022
Exponent, Inc. ( NASDAQ:EXPO ) will increase its dividend on the 25th of March to US$0.24. This makes the dividend...
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Exponent, Inc...
MENLO PARK, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors approved a $150 million expansion of its share repurchase program, adding to the $29.5 million that remains available under the current authorization for repurchases. In total, the Company now has approximately $179.5 million available to repurchase shares. The Company has repurchased $38.9 million of common stock in fiscal year 2022. “Today’s announcement, combined with
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the WisdomTree US.
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
On Monday, 71 stocks hit new 52-week lows. Noteable 52-Week Lows: 3M (NYSE:MMM) was the biggest company in ...
Exponent (NASDAQ:EXPO) reported its Q4 earnings results on Thursday, February 3, 2022 at 04:05 PM. Here's what investors need to ...
Exponent (EXPO) delivered earnings and revenue surprises of 5.56% and 2.14%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
MENLO PARK, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the fourth quarter and fiscal year 2021 ended December 31, 2021. “We finished the year strong, highlighting the exceptional performance of our team and resiliency of our business model. For the full year, net revenue grew 15%, driving a 343-basis point improvement in EBITDA1 margin compared to the prior-year period,” commented Dr. Catherine Corrigan, President and Chief Execut
MENLO PARK, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has raised its quarterly dividend by 20% from $0.20 to $0.24 per share of common stock. The quarterly cash dividend of $0.24 per share of common stock is to be paid on March 25, 2022 to all common stockholders of record as of March 11, 2022. “Exponent is deeply committed to delivering long-term value for our shareholders. In 2021, we returned $50.2 million to shareholder
Companies Reporting Before The Bell • Tuesday Morning (NASDAQ:TUEM) is likely to report earnings for its second ...
Exponent (EXPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..
Exponent, Inc (EXPO) is a NASDAQ Common Stock listed in Common Stock, Consulting Services, Industrials
